# Bioreliance Ltd. – FDA Inspection, Sep 27, 2019

Source: https://www.keypedia.com/records/fda_inspections/bioreliance-ltd/c26c2b64-49cf-4023-81ce-8b8422935fd5
Source feed: FDA_Inspections

> FDA inspection 1108960 of Bioreliance Ltd., September 27, 2019. Classification: Voluntary Action Indicated (VAI). Form 483 issued. 9 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1108960
- Company Name: Bioreliance Ltd.
- Inspection Date: 2019-09-27
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- [FDA Inspection 1288500 - 2025-12-05](https://www.keypedia.com/records/fda_inspections/bioreliance-ltd/e0050eb3-232d-48bc-a614-c2fa80560997)
- FDA Inspection 1225550 - 2023-11-07
- FDA Inspection 1202961 - 2021-03-17
- [FDA Inspection 1093195 - 2019-03-15](https://www.keypedia.com/records/fda_inspections/bioreliance-ltd/6d908b43-3b15-436a-839a-aaef7318e1d3)
- [FDA Inspection 1026860 - 2017-09-22](https://www.keypedia.com/records/fda_inspections/bioreliance-ltd/a56f5793-c36b-4041-8038-c123cd545822)

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/joey-v-quitania/faae874f-94ea-4b63-89d1-649e60726f6f)

Company: https://www.keypedia.com/companies/bioreliance-ltd/fec1a160-db6a-4ebc-9632-aa6e2996e17e

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
